Literature DB >> 8348745

Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.

A Matsukawa1, S Ohkawara, T Maeda, K Takagi, M Yoshinaga.   

Abstract

Injection of lipopolysaccharide (LPS) into rabbit knee joints provoked leucocyte infiltration and loss of proteoglycan (PG) from the cartilage. We investigated the role of IL-1 and IL-1 receptor antagonist (IL-1Ra) and its significance in the pathogenesis of LPS-arthritis. Production of IL-1 beta peaked at 6 h (196.7 +/- 89.4 pg/joint) after injection of 10 ng of LPS, while IL-1Ra peaked at 9 h (34.5 +/- 13.4 ng/joint). The amount of IL-1Ra was 180-200-fold molar excess of IL-1, and a large amount of IL-1Ra was sustained for 1 week. Both IL-1 beta and IL-1Ra were mainly produced by synovial exudate cells. Arthritis was reproduced by rabbit IL-1 beta. LPS-induced leucocyte infiltration was inhibited 70-75% by rabbit IL-1Ra. Loss of PG in LPS-arthritis was prevented by IL-1Ra and also by neutrophil elastase inhibitor, and superoxide dismutase. In leucopenic rabbits, injection of LPS induced neither production of IL-1 beta nor loss of PG. Direct injection of inflammatory exudated cells in leucopenic rabbits reproduced loss of PG, and there was only a partial recovery by IL-1Ra. These results suggest that LPS-initiated IL-1 acts as a key mediator in LPS-arthritis and that endogenous IL-1Ra may suppress a part of IL-1 activity at the site, but its amount was too low for suppression of the produced IL-1. Loss of PG is a sequela of infiltrated leucocytes and leucocyte-derived elastase, and superoxide anion may play a pivotal role in the destruction of cartilage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348745      PMCID: PMC1554844          DOI: 10.1111/j.1365-2249.1993.tb07967.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

Authors:  R W Farndale; D J Buttle; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1986-09-04

2.  The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center.

Authors:  D Johnson; J Travis
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

3.  Interferon in human serum after injection of endotoxin.

Authors:  C Sauter; C Wolfensberger
Journal:  Lancet       Date:  1980-10-18       Impact factor: 79.321

Review 4.  Elastase in tissue injury.

Authors:  A Janoff
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

Review 5.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

6.  Acute arthritis caused by gram-negative bacilli: a clinical characterization.

Authors:  D L Goldenberg; K D Brandt; E S Cathcart; A S Cohen
Journal:  Medicine (Baltimore)       Date:  1974-05       Impact factor: 1.889

Review 7.  The intracellular neutral SH-dependent protease associated with inflammatory reactions.

Authors:  H Hayashi
Journal:  Int Rev Cytol       Date:  1975

8.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

Review 9.  Rheumatoid arthritis. The role of neutrophil activation.

Authors:  G Weissmann; H Korchak
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

10.  Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

Authors:  J Saklatvala; L M Pilsworth; S J Sarsfield; J Gavrilovic; J K Heath
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

View more
  15 in total

1.  Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.

Authors:  J Arondel; M Singer; A Matsukawa; A Zychlinsky; P J Sansonetti
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits.

Authors:  T Fukumoto; A Matsukawa; S Ohkawara; K Takagi; M Yoshinaga
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

3.  Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster.

Authors:  I G Otterness; A J Milici; M L Bliven
Journal:  Agents Actions       Date:  1993-11

Review 4.  Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.

Authors:  M H Schiff
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  RANKL, OPG and CTR mRNA expression in the temporomandibular joint in rheumatoid arthritis.

Authors:  Wei-Wei Liu; Zhi-Min Xu; Zheng-Qiang Li; Yan Zhang; Bing Han
Journal:  Exp Ther Med       Date:  2015-07-08       Impact factor: 2.447

6.  Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Authors:  F W Tam; J Smith; S J Cashman; Y Wang; E M Thompson; A J Rees
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster.

Authors:  I G Otterness; M L Bliven; A J Milici; A R Poole
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 9.  Treatment of rheumatoid arthritis with IL-1 inhibitors.

Authors:  C Gabay; W P Arend
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Effects of exercise on synovium and cartilage from normal and inflamed knees.

Authors:  A K Shay; M L Bliven; D N Scampoli; I G Otterness; A J Milici
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.